Chundsell Medicals

About 90 percent of prostate cancers are benign whereas the rest are malign tumours which have to be treated with radical methods. Present diagnostics can’t separate these forms which bring about severe decisions. This dilemma is the basis for the novel test PCPT (Prostate Cancer Prediction Test).